Stockscreener 앱 받기
138.90
5.55%
7.256
시간 외 거래:
139.89
0.994
+0.72%
Repligen Corp 주식(RGEN)의 최신 뉴스
Cerity Partners LLC Has $613,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen (NASDAQ:RGEN) Cut to “Sell” at StockNews.com - Defense World
Repligen to Report First Quarter 2025 Financial Results - Yahoo Finance
Repligen Corp (RGEN) Shares Up 4.7% on Apr 11 - GuruFocus
Hollow Fiber Filtration Market Future Business Opportunities - openPR.com
Repligen’s 39% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com India
Repligen's 39% decline validates InvestingPro's bearish Fair Value call By Investing.com - Investing.com
Repligen (RGEN): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
StockNews.com Upgrades Repligen (NASDAQ:RGEN) to "Hold" - MarketBeat
Analysts’ Revisions Show Improving Sentiment For Repligen Corp (NASDAQ: RGEN) - stocksregister.com
Repligen Appoints Jacob Johnson As Vice President Investor Relations - Yahoo Finance
Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? - Yahoo Finance
Norges Bank Takes $24.03 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen (NASDAQ:RGEN) Upgraded at StockNews.com - The AM Reporter
Repligen (NASDAQ:RGEN) Raised to Hold at StockNews.com - Defense World
Repligen stock touches 52-week low at $113.24 amid market shifts By Investing.com - Investing.com South Africa
Repligen stock touches 52-week low at $113.24 amid market shifts - Investing.com
Groupama Asset Managment Purchases 400,680 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Corient Private Wealth LLC Trims Stake in Repligen Co. (NASDAQ:RGEN) - Defense World
HighTower Advisors LLC Sells 180 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (NASDAQ: RGEN): Getting A Free Pass? - Stocks Register
Repligen Co. (NASDAQ:RGEN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Global Hollow Fiber Filtration Market to Witness Massive Growth - openPR.com
Envestnet Portfolio Solutions Inc. Lowers Holdings in Repligen Co. (NASDAQ:RGEN) - The AM Reporter
Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? - Insider Monkey
Insider Buying: Margaret Pax Acquires Shares of Repligen Corp (R - GuruFocus
Repligen Corp (RGEN) Shares Gap Down to $139.34 on Mar 21 - GuruFocus.com
PNC Financial Services Group Inc. Sells 262 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp director Hunt Anthony sells $4.08 million in stock By Investing.com - Investing.com South Africa
Repligen Corp director Hunt Anthony sells $4.08 million in stock - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth and valuation challenges - Investing.com
Repligen (NASDAQ:RGEN) Coverage Initiated by Analysts at Evercore ISI - Defense World
Proficio Capital Partners LLC Makes New Investment in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Co. (NASDAQ:RGEN) Shares Sold by Victory Capital Management Inc. - Defense World
Repligen director Pax Margaret acquires $37,672 in common stock By Investing.com - Investing.com Australia
Repligen director Pax Margaret acquires $37,672 in common stock - Investing.com
REPLIGEN Director Margaret Pax Acquires 250 Shares - TradingView
Evercore ISI sets Repligen stock In Line with $155 price target - Investing.com
Demystifying Repligen: Insights From 6 Analyst Reviews - Benzinga
Repligen initiated with an In Line at Evercore ISI - TipRanks
Repligen Corp (RGEN) Shares Up 5.72% on Mar 17 - GuruFocus.com
Repligen Corp (RGEN) Shares Up 5.72% on Mar 15 - GuruFocus.com
REPLIGEN CORP SEC 10-K Report - TradingView
Charles Schwab Investment Management Inc. Grows Position in Repligen Co. (NASDAQ:RGEN) - Defense World
William Blair Brokers Reduce Earnings Estimates for Repligen - Defense World
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - The Globe and Mail
Oppenheimer & Co. Inc. Purchases New Shares in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
US Bancorp DE Raises Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
Sanctuary Advisors LLC Sells 268 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
1.60%
자본화:
|
볼륨(24시간):